文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

美国联邦监狱局COVID-19疫苗接种情况(2020年12月—2021年4月)

COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.
PubMed 文献 · Vaccine · 2021-08-14

该研究描述了美国联邦监狱局(BOP)2020年12月16日至2021年4月14日的COVID-19疫苗分发操作,报告了工作人员和被监禁者的接种覆盖率,并分析了被监禁者接种接受度的影响因素。结果显示,BOP已向全部37,870名工作人员和69.8%的被监禁者提供疫苗,接受率分别为50.2%和64.2%,且BOP的接种覆盖率与所在州/地区的整体成年人群相当。

要点

  • 截至2021年4月14日,BOP已向100%工作人员和69.8%被监禁者提供疫苗,接受率分别为50.2%和64.2%。
  • BOP接种覆盖率与所在州/地区的整体成年人群相当。
  • 被监禁者中,较低接受度与年轻、女性、非西班牙裔黑人和亚裔、较少基础疾病相关。

核心结论

  • BOP早期COVID-19疫苗接种努力达到了与一般人群相似的覆盖率。

研究设计与样本

  • 描述性分析BOP COVID-19疫苗接种计划和实施时间线,使用电子病历计算被监禁者接种覆盖率,使用CDC疫苗接种管理系统的数据计算工作人员覆盖率。
  • 通过单因素和多因素logistic回归模型分析被监禁者接种接受度相关因素,并采用分层线性模型处理机构层面聚类。

主要发现

  • 截至2021年4月14日,BOP已向37,870(100%)名工作人员和88,173/126,413(69.8%)名被监禁者提供COVID-19疫苗,接受率分别为50.2%和64.2%。
  • 在分析时,BOP的疫苗接种覆盖率与BOP机构和办公室所在州/地区的整体成年人群覆盖率相当。
  • 被监禁者中,与较低接种接受度相关的因素包括较年轻年龄、女性、非西班牙裔黑人和亚裔种族/族裔、以及较少的基础疾病;与较高接受度相关的因素包括既往SARS-CoV-2感染、在美国境外出生、以及被分配至联邦拘留中心。

临床怎么用

  • BOP可考虑重新向最初拒绝接种的人提供疫苗,并针对接受率较低的群体定制沟通策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe COVID-19 vaccine distribution operations in United States Federal Bureau of Prisons (BOP) institutions and offices from December 16, 2020-April 14, 2021, report vaccination coverage among staff and incarcerated people, and identify factors associated with vaccination acceptance among incarcerated people. METHODS: The BOP COVID-19 vaccination plan and implementation timeline are described. Descriptive statistics and vaccination coverage were calculated for the BOP incarcerated population using data from the BOP electronic medical record. Coverage among staff was calculated using data from the Centers for Disease Control and Prevention Vaccination Administration Management System. Vaccination coverage in the BOP versus the overall United States adult population was compared by state/territory. Univariate and multivariable logistic regression models were developed to identify demographic, health-related, and institution-level factors associated with vaccination acceptance among incarcerated people, using hierarchical linear modeling to account for institution-level clustering. RESULTS: By April 14, 2021, BOP had offered COVID-19 vaccination to 37,870 (100%) staff and 88,173/126,413 (69.8%) incarcerated people, with acceptance rates of 50.2% and 64.2%, respectively. At the time of analysis, vaccination coverage in BOP was comparable to coverage in the overall adult population in the states and territories where BOP institutions and offices are located. Among incarcerated people, factors associated with lower vaccination acceptance included younger age, female sex, non-Hispanic Black and Asian race/ethnicity, and having few underlying medical conditions; factors associated with higher acceptance included having a prior SARS-CoV-2 infection, being born outside the United States, and being assigned to a Federal Detention Center. CONCLUSIONS: Early COVID-19 vaccination efforts in BOP have achieved levels of coverage similar to the general population. To build on this initial success, BOP can consider strategies including re-offering vaccination to people who initially refused and tailoring communication strategies to groups with lower acceptance rates.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hagan LM, Dusseau C, Crockett M, et al. COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021. Vaccine. 2021. PMID: 34465473. doi:10.1016/j.vaccine.2021.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。